Jim A. Wright
13Patents
5h-index
8Co-inventors
55Inventor score
Filing activity: Jun 30, 1997 → Jan 21, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6121000A | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | Chemistry; Metallurgy | 34 | Expired |
| US5998383A | Antitumor antisense sequences directed against ribonucleotide reductase | Chemistry; Metallurgy | 33 | Expired |
| US6566514B1 | Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth | Chemistry; Metallurgy | 13 | Expired |
| US8148392B2 | 2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use in the treatment of cancer | Human Necessities | 9 | Active |
| US6417169B1 | Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth | Chemistry; Metallurgy | 5 | Expired |
| US8287851B2 | Use of interleukin 17E for the treatment of cancer | Chemistry; Metallurgy | 4 | Active |
| US6593305B1 | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | Chemistry; Metallurgy | 3 | Expired |
| US6610539B1 | Antisense oligonucleotide sequences as inhibitors of microorganisms | Chemistry; Metallurgy | 2 | Expired |
| US7405205B2 | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | Chemistry; Metallurgy | 1 | Expired |
| US6472376B2 | Suppression of malignancy utilizing ribonucleotide reductase R1 | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7087580B2 | Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth | Chemistry; Metallurgy | 0 | Expired |
| US7223849B1 | Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth | Chemistry; Metallurgy | 0 | Expired |
| US7968526B2 | Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.